-
Something wrong with this record ?
Long-term outcome of Simpson IV meningioma resection: Would it improve with adjuvant SRS
M. Dedeciusova, M. Majovsky, L. Pecen, V. Benes, D. Netuka
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
ProQuest Central
from 2002-01-01 to 2 months ago
Health & Medicine (ProQuest)
from 2002-01-01 to 2 months ago
Psychology Database (ProQuest)
from 2002-01-01 to 2 months ago
- MeSH
- Radiotherapy, Adjuvant MeSH
- Time Factors MeSH
- Progression-Free Survival MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Meningeal Neoplasms mortality pathology surgery MeSH
- Meningioma mortality pathology surgery MeSH
- Survival Rate MeSH
- Radiosurgery MeSH
- Retrospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Neoplasm Grading MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
OBJECTIVE: Subtotal meningioma resection (STR) is often performed to minimize surgical morbidity. Nevertheless, only a few studies have reported on patient outcome after STR. We studied the long-term outcome of SIV (Simpson grade IV) resection and identified predictive factors of overall survival (OS), progression-free survival (PFS) and time to progression (TTP). METHODS: A retrospective analysis was performed on 68 patients who underwent SIV resection of meningioma (grade I) from 2004 to 2010. Data were collected from clinical, surgical and pathology records and radiological imaging. Long-term outcomes were evaluated at least 10 years after surgery. RESULTS: Permanent morbidity was 11.8%, 30-day mortality 2.9% and progression rate 50.0% for a median follow-up duration of 126.6 months. Median TTP was 86.2 months. Adjuvant SRS was the only significant factor associated with longer PFS (p = 0.0052) and TTP (p = 0.0079). Higher age (p = 0.0022), KPS (p = 0.0182), postoperative ECOG score (p = 0.0182) were reliable predictors of shortened OS and aSRS (p = 0.0445) was reliable predictor of longer OS. CONCLUSION: STR in intracranial meningioma is still viable and often the only treatment option available in high-risk patients or high-risk tumors. Although surgical morbidity and mortality are high, the OS rate was 85.3% at 5 years and 79.4% at 10 years. Because of the considerable progression rate and rather a long term OS the adjuvant SRS should be considered following SIV resection.
1st Faculty of Medicine Charles University Prague Prague Czech Republic
Institute of Computer Science The Czech Academy of Sciences Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22012311
- 003
- CZ-PrNML
- 005
- 20220506125839.0
- 007
- ta
- 008
- 220425s2021 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.clineuro.2021.106766 $2 doi
- 035 __
- $a (PubMed)34166979
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Dedeciusova, Michaela $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic; First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. Electronic address: michaela.dedeciusova@seznam.cz
- 245 10
- $a Long-term outcome of Simpson IV meningioma resection: Would it improve with adjuvant SRS / $c M. Dedeciusova, M. Majovsky, L. Pecen, V. Benes, D. Netuka
- 520 9_
- $a OBJECTIVE: Subtotal meningioma resection (STR) is often performed to minimize surgical morbidity. Nevertheless, only a few studies have reported on patient outcome after STR. We studied the long-term outcome of SIV (Simpson grade IV) resection and identified predictive factors of overall survival (OS), progression-free survival (PFS) and time to progression (TTP). METHODS: A retrospective analysis was performed on 68 patients who underwent SIV resection of meningioma (grade I) from 2004 to 2010. Data were collected from clinical, surgical and pathology records and radiological imaging. Long-term outcomes were evaluated at least 10 years after surgery. RESULTS: Permanent morbidity was 11.8%, 30-day mortality 2.9% and progression rate 50.0% for a median follow-up duration of 126.6 months. Median TTP was 86.2 months. Adjuvant SRS was the only significant factor associated with longer PFS (p = 0.0052) and TTP (p = 0.0079). Higher age (p = 0.0022), KPS (p = 0.0182), postoperative ECOG score (p = 0.0182) were reliable predictors of shortened OS and aSRS (p = 0.0445) was reliable predictor of longer OS. CONCLUSION: STR in intracranial meningioma is still viable and often the only treatment option available in high-risk patients or high-risk tumors. Although surgical morbidity and mortality are high, the OS rate was 85.3% at 5 years and 79.4% at 10 years. Because of the considerable progression rate and rather a long term OS the adjuvant SRS should be considered following SIV resection.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a meningeální nádory $x mortalita $x patologie $x chirurgie $7 D008577
- 650 _2
- $a meningeom $x mortalita $x patologie $x chirurgie $7 D008579
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a stupeň nádoru $7 D060787
- 650 _2
- $a doba přežití bez progrese choroby $7 D000077982
- 650 _2
- $a radiochirurgie $7 D016634
- 650 _2
- $a adjuvantní radioterapie $7 D018714
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a míra přežití $7 D015996
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Majovsky, Martin $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic; First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Pecen, Ladislav $u Institute of Computer Science, The Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Benes, Vladimir $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic; First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 700 1_
- $a Netuka, David $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic; First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 773 0_
- $w MED00001144 $t Clinical neurology and neurosurgery $x 1872-6968 $g Roč. 207, č. - (2021), s. 106766
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34166979 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506125831 $b ABA008
- 999 __
- $a ok $b bmc $g 1789759 $s 1163512
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 207 $c - $d 106766 $e 20210617 $i 1872-6968 $m Clinical neurology and neurosurgery $n Clin Neurol Neurosurg $x MED00001144
- LZP __
- $a Pubmed-20220425